Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
US is best positioned to fill India’s natural gas needs: Energy Secretary
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email U.S. Energy Secretary Dan Brouillette talks about the strategic energy partnership with India, and how it will boost trade in oil and natural gas. 03:23 Wed, Feb 26 202012:56 AM EST
Behind the Scenes: Suze
Suze Orman offers a behind the scenes look at her show.
Boeing CEO Dave Calhoun calls the Alaska Airlines incident a ‘mistake’ that should never happen
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Boeing CEO Dave Calhoun joins ‘The Exchange’ to discuss the Alaska Airlines incident, how the company is addressing this, and more. 04:00 Wed, Jan 10 20241:22 PM EST
Jim Cramer’s guide to investing: How to trade around a core position
CNBC’s Jim Cramer said he knows he usually tells investors to own stocks for the long haul, not trade for gains in the short-term. But trading around a core position is a basic and useful discipline, he said. When trading around a core position, investors maintain a long-term investment – the core position – but…
Jim Cramer says investors should remember the optionality of 6 of the Magnificent 7
CNBC’s Jim Cramer keyed in on the optionality of six of the companies that have become known as the “Magnificent Seven” during his Wednesday show. “The Magnificent Seven have the most optionality of any publicly traded companies in modern history,” Cramer said. “To sell any of them is to forget that they have this kind…
UBS Global Wealth Management is ‘overweight’ on Asia ex-Japan stocks
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Adrian Zuercher of UBS Global Wealth Management says stocks in Asia ex-Japan may be “the only region” that will have positive earnings growth this year. 03:31 Wed, Jun 3 20206:36 AM EDT
